InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Roche Holding Ltd. Director active across 2 companies, notably Entrada Therapeutics, Inc.. In total, 2 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €130k. Activity tracked since 25 January 2023. The latest transaction was disclosed on 25 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations